"Global STD Diagnostics Market Overview:
Global STD Diagnostics Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global STD Diagnostics Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of STD Diagnostics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the STD Diagnostics Market:
The STD Diagnostics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for STD Diagnostics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study STD Diagnostics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, STD Diagnostics market has been segmented into:
Chlamydia Testing
Gonorrhea Testing
By Application, STD Diagnostics market has been segmented into:
Laboratory Tests
Point of Care Tests
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The STD Diagnostics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the STD Diagnostics market.
Top Key Players Covered in STD Diagnostics market are:
Abbott Laboratories
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific
Inc.
Becton
Dickinson and Company
BIOMÉRIEUX
Bio-Rad Laboratories
Inc.
Danaher
DiaSorin S.p.A.
QuidelOrtho Corporation
Hologic
Inc.
OraSure Technologies
Siemens
Illumina Inc.
See-gene Inc.
Qiagen
MedMira Inc.
Cepheid.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: STD Diagnostics Market by Type
4.1 STD Diagnostics Market Snapshot and Growth Engine
4.2 STD Diagnostics Market Overview
4.3 Chlamydia Testing
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Chlamydia Testing: Geographic Segmentation Analysis
4.4 Gonorrhea Testing
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Gonorrhea Testing: Geographic Segmentation Analysis
Chapter 5: STD Diagnostics Market by Application
5.1 STD Diagnostics Market Snapshot and Growth Engine
5.2 STD Diagnostics Market Overview
5.3 Laboratory Tests
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Laboratory Tests: Geographic Segmentation Analysis
5.4 Point of Care Tests
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Point of Care Tests: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 STD Diagnostics Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT LABORATORIES
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 F. HOFFMANN-LA ROCHE LTD
6.4 THERMO FISHER SCIENTIFIC
6.5 INC.
6.6 BECTON
6.7 DICKINSON AND COMPANY
6.8 BIOMÉRIEUX
6.9 BIO-RAD LABORATORIES
6.10 INC.
6.11 DANAHER
6.12 DIASORIN S.P.A.
6.13 QUIDELORTHO CORPORATION
6.14 HOLOGIC
6.15 INC.
6.16 ORASURE TECHNOLOGIES
6.17 SIEMENS
6.18 ILLUMINA INC.
6.19 SEE-GENE INC.
6.20 QIAGEN
6.21 MEDMIRA INC.
6.22 AND CEPHEID.
Chapter 7: Global STD Diagnostics Market By Region
7.1 Overview
7.2. North America STD Diagnostics Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Chlamydia Testing
7.2.4.2 Gonorrhea Testing
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Laboratory Tests
7.2.5.2 Point of Care Tests
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe STD Diagnostics Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Chlamydia Testing
7.3.4.2 Gonorrhea Testing
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Laboratory Tests
7.3.5.2 Point of Care Tests
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe STD Diagnostics Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Chlamydia Testing
7.4.4.2 Gonorrhea Testing
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Laboratory Tests
7.4.5.2 Point of Care Tests
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific STD Diagnostics Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Chlamydia Testing
7.5.4.2 Gonorrhea Testing
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Laboratory Tests
7.5.5.2 Point of Care Tests
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa STD Diagnostics Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Chlamydia Testing
7.6.4.2 Gonorrhea Testing
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Laboratory Tests
7.6.5.2 Point of Care Tests
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America STD Diagnostics Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Chlamydia Testing
7.7.4.2 Gonorrhea Testing
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Laboratory Tests
7.7.5.2 Point of Care Tests
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
STD Diagnostics Scope:
|
Report Data
|
STD Diagnostics Market
|
|
STD Diagnostics Market Size in 2025
|
USD XX million
|
|
STD Diagnostics CAGR 2025 - 2032
|
XX%
|
|
STD Diagnostics Base Year
|
2024
|
|
STD Diagnostics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Laboratories, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, BIOMÉRIEUX, Bio-Rad Laboratories, Inc., Danaher, DiaSorin S.p.A., QuidelOrtho Corporation, Hologic, Inc., OraSure Technologies, Siemens, Illumina Inc., See-gene Inc., Qiagen, MedMira Inc., and Cepheid..
|
|
Key Segments
|
By Type
Chlamydia Testing
Gonorrhea Testing
By Applications
Laboratory Tests
Point of Care Tests
|
